Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: comparison with the liver parenchyma and correlation with the survival of patients …
Radiology, 2017•pubs.rsna.org
A previously issued erratum (http://dx. doi. org/10.1148/radiol. 2016164030) regarding this
article was incorrect. Page 461, Figure 2 legend should read as follows: For group 1 (blue
line) versus group 3 (red line), median survival was 174 days and 110 days, respectively,
and P=. 024. For group 2 (green line) versus group 3 (red line), median survival was 193
days and 110 days, respectively, and P=. 001. No difference was observed between the two
systemic therapy groups (group 1 vs group 2, median survival= 174 days vs 193 days, P …
article was incorrect. Page 461, Figure 2 legend should read as follows: For group 1 (blue
line) versus group 3 (red line), median survival was 174 days and 110 days, respectively,
and P=. 024. For group 2 (green line) versus group 3 (red line), median survival was 193
days and 110 days, respectively, and P=. 001. No difference was observed between the two
systemic therapy groups (group 1 vs group 2, median survival= 174 days vs 193 days, P …
A previously issued erratum (http://dx. doi. org/10.1148/radiol. 2016164030) regarding this article was incorrect. Page 461, Figure 2 legend should read as follows: For group 1 (blue line) versus group 3 (red line), median survival was 174 days and 110 days, respectively, and P=. 024. For group 2 (green line) versus group 3 (red line), median survival was 193 days and 110 days, respectively, and P=. 001. No difference was observed between the two systemic therapy groups (group 1 vs group 2, median survival= 174 days vs 193 days, P=. 768).
Radiological Society of North America